𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The intravascular contrast agent Clariscan™ (NC 100150 injection) for 3D MR coronary angiography in patients with coronary artery disease

✍ Scribed by Christoph Klein; Eike Nagel; Bernhard Schnackenburg; Axel Bornstedt; Simon Schalla; Volker Hoffmann; Anja Lehning; Eckart Fleck

Book ID
110620740
Publisher
Springer
Year
2000
Tongue
English
Weight
252 KB
Volume
11
Category
Article
ISSN
0968-5243

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Initial experience with the intravascula
Initial experience with the intravascular contrast agent NC100150-injection (Clariscan®) for breath-hold and navigator-gated magnetic resonance coronary artery imaging
✍ Nicholas H. Bunce; Jennifer Keegan; Peter D. Gatehouse; James C.C. Moon; David N 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 803 KB

## Abstract ## Purpose To examine magnetic resonance coronary artery imaging after NC100150‐Injection. ## Materials and Methods Breath‐hold and navigator‐gated images were acquired in five patients. ## Results Breath‐hold image quality, coronary artery‐fat SDNR, and coronary artery SNR improve

Improvement of image quality of non-inva
Improvement of image quality of non-invasive coronary artery imaging with magnetic resonance by the use of the intravascular contrast agent Clariscan™ (NC100150 injection) in patients with coronary artery disease
✍ Christoph Klein; Simon Schalla; Bernhard Schnackenburg; Axel Bornstedt; Volker H 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 803 KB

## Abstract ## Purpose To assess the feasibility of Clariscan™, an intravascular contrast agent, for free breathing, navigator assisted, high resolution, three‐dimensional‐magnetic resonance coronary angiography (MRCA) in patients, as extracellular contrast agents are unfavorable for the improveme